(Alumna) Hiroko Shimada, MD, PhD

Professional experience
2012-2013 Nephrologist and Internist, Sugiyama hospital in Nagoya
2011-2012 Chief of medical section, Aichi Blood Center of Japanese Red Cross Society
2010-2011 Nephrologist and Internist,, Aso Clinic in Miyazaki
2005-2007 Nephrologist and Internist,, Kenritsu Nichinan Hospital
2004-2005 Nephrologist and Internist,, Miyazaki Konan Hospital
2001-2004 Nephrologist, Kidney Center, Koga General Hospital in Miyazaki
1996-1997 Nephrologist and Internist,  Miyazaki Konan Hospital
1995-1996 Nephrologist and Internist,, Kenritsu Nichinan Hospital
1994-1995 Internist,Mimata Choritsu Hospital
1992-1994 Resident of Internal Medicine, University of Medical Hospital, Kenritsu Miyazaki Hospital
 
Education
1997-2001 Ph.D. Nephrology   First department of Internal Medicine, University of Miyazaki
1986-1992 M.D.               Faculty of Medicine, University of Miyazaki
 
Teaching experience   
2007-2010  Biochemistry and Internal Medicine, Department of Nutrition Management, Minami Kyusyu University
 
Publications
1) Fukae H, Kinoshita H, Fujimoto S, Nakazato M, Eto T: Plasma concentration of uroguanylin in patients on maintenance dialysis therapy. Nephron 84: 206-210, 2000
2) Fukae H, Kinoshita H, Fujimoto S, Kita T, Nakazato M, Eto T: Changes in urinary levels and renal expression of uroguanylin on low or high salt diets in rats. Nephron 92: 373-378, 2002.
 
Presentations
1) Fukae H, Kinoshita H, Fujimoto S, Kita T, Eto T: Changes in urinary levels and renal expression of uroguanylin, a novel natriuretic peptide, on low or high salt diets.
ASN/ISN World Congress of Nephrology, 2001-10 (San Francisco, USA)
2) Fukae H, Ishihara T, Hayashi E, Imadzu Y, Hiratsuka T, Fujiura Y, Ikushima I, Ishizaki J, Ageta M: The research of progress factors on chronic kidney disease (CKD) – associated with atherosclerosis. XIV International Symposium on Atherosclerosis, 2006-6 (Roma, Italy)
3) Fukae H, Ishihara T, Hayashi E, Ikushima I, Ishizaki J, Ageta M: Low HDL-Cholesterol is a prognosis or incidence determinant factor of renal function in the patients with hypertension, Diabetes mellitus and/or hyperlipidemia, XVI International Symposium on Drugs Affecting Lipid Metabolism 2007 (New York, USA)
 
Membership
Japanese Society of Nephrology, The Japanese Society of Internal Medicine, The Japanese Society for Dialysis Therapy